Shanghai Pharmaceuticals (601607.SH) plans to invest 300 million yuan to establish the Shanghai Shangshi Biopharmaceutical Industry Private Equity Fund.

Zhtng Cijng APP News, Shanghai Pharmaceuticals (601607.SH) announced that the company plans to participate in the establishment of Shanghai Shangshi Biopharmaceutical Industry Private Equity Fund Partnership Enterprise (Limited Partnership) as one of the limited partners, with a proposed investment amount of 300 million yuan. The target fundraising size of the fund is 2 billion yuan.